⌘K

Login Start Free

Home/Filings/4/0001493152-23-028474

4//SEC Filing

Hsu Jason 4

Accession 0001493152-23-028474

CIK 0001873835other

View on SEC.gov Company Profile

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 4:15 PM ET

Size

5.2 KB

Accession

0001493152-23-028474

Insider Transaction Report

Form 4

Period: 2023-08-11

Immix Biopharma, Inc.IMMX

Director

Transactions

Award
Stock Options
2023-08-11+20,000→ 20,000 total
Exercise: $1.86Exp: 2033-08-11→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]Options vest monthly over 12 months from the date of grant.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Immix Biopharma, Inc.

CIK 0001873835

Entity typeother

Related Parties

1

filerCIK 0001895035

Filing Metadata

Form type: 4
Filed: Aug 13, 8:00 PM ET
Accepted: Aug 14, 4:15 PM ET
Size: 5.2 KB

View on SEC.gov